The Ramco Cements has commissioned Phase I and II waste recovery plants at its Jayanthipuram plant.
The company has plans to install 27 MW of waste heat recovery plants in all the three lines of clinker manufacturing, including the proposed third Line, which is nearing completion.
The Phase I of the waste heat recovery plant of 9 MW capacity was commissioned in September 2020 and is producing its full capacity.
The Phase II of 9 MW capacity has been completed and commissioned on 28 February 2021. The Phase III of 9 MW is scheduled to be commissioned, after commissioning of the Line III of the clinkerisation plant.
ADC Contract Manufacturing Market, 2020-2030
New York, Dec. 11, 2020 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report ADC Contract Manufacturing Market, 2020-2030 - https://www.reportlinker.com/p03290025/?utm source=GNW Over time, clinical researchers have been able to further their understanding of the intricacies of ADC design and have also improved the development process of these complex pharmacological interventions. Some of the recently approved ADC therapeutics include BLENREP® (2020), TRODELVYTM (2020), PadcevTM (2019) and POLIVY® (2019). In addition, there are close to 250 unique ADC product candidates under development. Several big pharma players, including AstraZeneca, GlaxoSmithKline, Pfizer, Roche and Takeda, have also acquired stake in this market. Moreover, the fact that companies involved in the development of ADCs, have received over USD 5 billion in capital investments (since 2011), attests to the therapeutic potential and growing p